Connected Patient Care at all Times
HackensackUMC was among the first hospitals in New Jersey to offer cardiac patients with non-valvular atrial fibrillation (AF) an alternative to long-term warfarin medication with the newly-approved WATCHMAN Left Atrial Appendage Closure (LAAC) Implant.
The WATCHMAN Implant is an alternative to blood thinners to reduce a patient’s risk of AF-related stroke. The WATCHMAN Implant closes off an area of the heart called the left atrial appendage (LAA) to keep harmful blood clots from the LAA from entering the blood stream and potentially causing a stroke. By closing off the LAA, the risk of stroke may be reduced and, over time, patients may be able to stop taking warfarin.
HackensackUMC is one of only two hospitals in the New York Metropolitan area to offer targeted breast tissue localization through the SAVI SCOUT® surgical guidance system. The SAVI SCOUT® surgical guidance system is used by HackensackUMC surgeons and radiologists to precisely locate and direct the removal of specific breast tissue during a breast lumpectomy for cancer or for a surgical breast biopsy procedure. The ability to precisely locate a tumor enables the surgeon complete cancer removal and reduces the likelihood of needing follow-up surgeries – a huge advancement for breast cancer patients. Click here to see Dr. Max Gomez explaining the SAVI SCOUT on CBS2 News.
Advancing the treatment in women’s cancers, HackensackUMC is involved in a clinical trial using Firefly technology to identify metastatic cancer in the pelvic area. The da Vinci® Si Surgical System with integrated fluorescence imaging capability provides real-time, image-guided identification of key anatomical landmarks using near-infrared technology. Fluorescence imaging allows surgeons to see and assess anatomy better than the naked eye, further enhancing the unique vision, precision and control of minimally invasive da Vinci surgery. This helps the surgeon identify sentinel nodes in endometrial or cervical cancers and may help a patient avoid a full lymphatomectomy and the symptoms that follow.
HackensackUMC is the first hospital in New Jersey to offer Mazor Robotics Renaissance Spine Surgery®, the state-of-the-art, minimally-invasive guidance system that can mean faster recovery and less pain for patients. Mazor Robotics technology has been clinically validated to ensure 1.5mm accuracy for increased patient safety compared to freehand spine surgery. Surgeons use Renaissance to pre-plan the optimal surgery in a CT-based 3-D simulation of the patient’s spine. During surgery, Renaissance guides the surgeon’s hand and tools to the precise pre-planned location.
Click here to learn more about Mazor Robotic Surgery.
At HackensackUMC, we continually incorporate technologies and services that meet the changing needs of healthcare delivery in the 21st century. The HackensackUMC Mobile Access app is one of many initiatives we are supporting to enhance our patients’ experiences and transform HackensackUMC into a truly integrated and patient-centered institution.
The new smartphone app allows patients to access their medical data, search for and connect with HackensackUMC physicians, make appointments and more.
The HackensackUMC Mobile Access app is a valuable, new tool to help patients easily access the information they need, and to feel empowered to take ownership of their healthcare. The app can be found in the iTunes store and on Google Play.
HackensackUMC was selected to join the President of the United States’ Precision Medicine Initiative to accelerate a new era of medicine that delivers the right treatment at the right time to the right person, taking into account individuals’ health history, genes, environments, and lifestyles. The Information Technology team and Dr. Shafiq Rab, vice president and chief information officer are leading the way in providing individuals access to their clinical data, enabling connections with applications that allow patients to donate their data to support precision medicine research. To facilitate robust patient access, HackensackUMC commits to developing and implementing open, vendor-neutral standards as part of the Argonaut Project, and adopting Fast Healthcare Interoperability Resources ("FIRE"), a next-generation API-based standard for exchanging health information.
More than 40 private-sector organizations including HackensackUMC are making commitments that will accelerate precision medicine, in alignment with the key principles of the Precision Medicine Initiative to: make it easier for patients to access, understand, and share their own digital health data, including donating it for research; engage participants as partners in research, including returning results to them in dynamic, user-centered ways; bring the promise of precision medicine to everyone; open up data and technology tools to invite citizen participation, unleash new discoveries, and bring together diverse collaborators to share their unique skills.
HackensackUMC has advanced treatment in emergent and elective endovascular thoracic vascular procedures by employing a new device that simplifies complex cases and reduces risks. Working in collaboration with Cook Medical, HackensackUMC participated in clinical trials that led to FDA approval of the lowest-profile, minimally-invasive endovascular thoracic stent graft.
In the first known case of its kind in the United States, Dr. Michael Wilderman, chief of Endovascular Surgery at HackensackUMC, placed the device in a ruptured and dissecting thoracic aneurysm. Dr. Wilderman continues to perform successful endovascular thoracic aneurysm repairs using this new technology.
HackensackUMC adopted an innovative strategy that integrates new technologies to achieve an accurate measure of blood loss. The approach will allow healthcare providers to better assess maternal blood loss in obstetrics and reduce maternal postpartum hemorrhages, placing HackensackUMC on the forefront of obstetrics and maternal health. This system allows nurses, obstetricians and anesthesiologists to initiate an early warning system for blood loss in obstetrics and postpartum hemorrhage.
HackensackUMC is the first hospital in the United States to integrate Triton – the world’s first and only FDA-cleared technology for real-time monitoring of surgical blood loss – with the Department of Obstetrics’ electronic medical record system, Epic – in order to determine Quantified Blood Loss in patients.
Using the Triton iPad application, healthcare providers capture scans of sponges and canisters during surgery. The images are uploaded to Gauss Surgical’s secure cloud, which processes the images and determines the amount of blood lost. Within a few seconds, the results are automatically uploaded to Epic, which immediately alerts physicians and nurses of blood loss levels and potentially critical levels of loss for each individualized patient.
Click here to see Dr. Andrew Rubenstein and Dr. Shafiq Rab on Caucus NJ with Steve Adubato explaining the Triton system.
Hackensack University Health Network has partnered with American Well, a leading national telehealth company, to provide telehealth services within the health network. ConvenientCare Now by Hackensack University Health Network will be available through the use of smartphones, tablets, mobile devices or online video - patients will have access to quality physicians any time of day.
ConvenientCare Now continues the commitment to improving the health of populations entrusted to the Hackensack University Health Network. The telehealth system which connects patients directly with providers in real-time, offers a convenient, accessible, patient-centered solution for non-emergent healthcare.